XML 25 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Aug. 31, 2022   41,653,218        
Beginning balance at Aug. 31, 2022 $ 1,331,408 $ 417 $ 1,190,350 $ (930,715) $ 1,179,739 $ (108,383)
Beginning balance, treasury stock (in shares) at Aug. 31, 2022       3,608,462    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 468,173       468,173  
Other comprehensive income (loss) 21,242         21,242
Common stock issued for employee stock plans (in shares)   360,375   410    
Common stock issued for employee stock plans 71,840 $ 3 72,003 $ (166)    
Vesting of restricted stock (in shares)   83,035   32,034    
Vesting of restricted stock (13,544) $ 1 (1) $ (13,544)    
Excise tax on share repurchases $ (932)     $ (932)    
Repurchase of common stock (in shares) 430,350     430,350    
Repurchases of common stock $ (176,720)     $ (176,720)    
Stock-based compensation expense 62,038   62,038      
Dividends declared (142,816)       (142,816)  
Other (759)   (759)      
Balance, end of period (in shares) at Aug. 31, 2023   42,096,628        
Ending balance at Aug. 31, 2023 1,619,930 $ 421 1,323,631 $ (1,122,077) 1,505,096 (87,141)
Ending balance, treasury stock (in shares) at Aug. 31, 2023       4,071,256    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 537,126       537,126  
Other comprehensive income (loss) 7,528         7,528
Common stock issued for employee stock plans (in shares)   407,542   831    
Common stock issued for employee stock plans 91,336 $ 4 91,708 $ (376)    
Vesting of restricted stock (in shares)   94,745   36,758    
Vesting of restricted stock (16,283) $ 1 (1) $ (16,283)    
Excise tax on share repurchases $ (1,725)     $ (1,725)    
Repurchase of common stock (in shares) 537,800     537,800    
Repurchases of common stock $ (235,235)     $ (235,235)    
Stock-based compensation expense 63,501   63,501      
Dividends declared $ (153,718)       (153,718)  
Balance, end of period (in shares) at Aug. 31, 2024 37,952,270 42,598,915        
Ending balance at Aug. 31, 2024 $ 1,912,460 $ 426 1,478,839 $ (1,375,696) 1,888,504 (79,613)
Ending balance, treasury stock (in shares) at Aug. 31, 2024 4,646,645     4,646,645    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 597,040       597,040  
Other comprehensive income (loss) 15,865         15,865
Common stock issued for employee stock plans (in shares)   325,030   370    
Common stock issued for employee stock plans 81,519 $ 3 81,686 $ (170)    
Vesting of restricted stock (in shares)   89,321   35,421    
Vesting of restricted stock (16,072) $ 1 (1) $ (16,072)    
Excise tax on share repurchases $ (3,034)     $ (3,034)    
Repurchase of common stock (in shares) 684,960     684,960    
Repurchases of common stock $ (300,457)     $ (300,457)    
Stock-based compensation expense 61,229   61,229      
Dividends declared $ (162,137)       (162,137)  
Balance, end of period (in shares) at Aug. 31, 2025 37,645,870 43,013,266        
Ending balance at Aug. 31, 2025 $ 2,186,413 $ 430 $ 1,621,753 $ (1,695,429) $ 2,323,407 $ (63,748)
Ending balance, treasury stock (in shares) at Aug. 31, 2025 5,367,396     5,367,396